<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<!--<?xml-stylesheet type="text/xsl" href="article.xsl"?>-->
<article article-type="research-article" dtd-version="1.0" xml:lang="en"
    xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <front>
        <journal-meta>
            <journal-id journal-id-type="issn">0973-7510</journal-id>
            <journal-title-group>
                <journal-title>Journal of Pure and Applied Microbiology</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2581-690X</issn>
            <publisher>
                <publisher-name>DR. M.N. Khan</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.22207/JPAM.20.3.44</article-id>
            <title-group>
                <article-title>Emerging ESBL and Carbapenem-resistance among Urinary Isolates in a Tertiary Care Setting</article-title>
            </title-group>
 
			<contrib-group>


				<contrib contrib-type="author">
                    <name>
                        <surname>Ghogale</surname>
                        <given-names>Shital Shrikant</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
			
			
				<contrib contrib-type="author">
                    <name>
                        <surname>Pathak</surname>
                        <given-names>Ketaki Niranjan</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
				
			</contrib-group>


                    <aff id="aff-1">Department of Microbiology, Symbiosis Medical College for Women and Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, Maharashtra, India.</aff>


            <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-09-01">
                <day>01</day>
				<month>09</month>
                <year>2026</year>
            </pub-date>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>2481</fpage>
            <lpage>2489</lpage>
            <permissions>
                <copyright-statement>Copyright &#x00A9; 2026 The Author(s)</copyright-statement>
                <copyright-year>2026</copyright-year>
                <license license-type="open-access"
                    xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.<uri
					xlink:href="https://creativecommons.org/licenses/by/4.0/"
                            >https://creativecommons.org/licenses/by/4.0/</uri></license-p>
                </license>
            </permissions>
            <self-uri xlink:href="https://microbiologyjournal.org/emerging-esbl-and-carbapenem-resistance-among-urinary-isolates-in-a-tertiary-care-setting/"/>
            <abstract>
                <p>Urinary tract infections are among the most common bacterial infections in clinical practice, and increasing antimicrobial resistance among uropathogens poses a serious challenge to empirical therapy, especially in tertiary care settings. In this study, we analyzed culture positivity rate, bacteriological profile, and distribution of urine isolates by patient location in a tertiary care hospital. This retrospective laboratory-based study was conducted in the Department of Microbiology of a tertiary care teaching hospital between January 2024 and December 2024. Urine samples were processed using standard semiquantitative culture techniques on cystine lactose electrolyte-deficient medium. Organism identification and antimicrobial susceptibility testing were performed using an automated BD Phoenix™ system. Extended-spectrum β-lactamase (ESBL) and carbapenem-resistance detection were interpreted according to Clinical and Laboratory Standards Institute guidelines. Of 3434 urine samples processed, 857 (24.9%) showed significant bacterial growth. Gram-negative bacilli predominated (77.4%), whereas Gram-positive cocci accounted for 22.6%. Culture positivity rate was higher among inpatients than outpatients. Among Gram-negative isolates, ESBL production was most common in Escherichia coli (63.4%; 312/492), and Klebsiella spp. (24.4%; 120/492). Carbapenem-resistant isolates included E. coli (47.4%, 81/171), Klebsiella spp. (28.1%, 48/171), Pseudomonas aeruginosa (14.0%, 24/171), and Acinetobacter spp. (7.0%, 12/171). ESBL producers demonstrated high resistance to cephalosporins and fluoroquinolones, with better susceptibility to nitrofurantoin, amikacin, and meropenem. Colistin retained the highest activity against carbapenem-resistant isolates (81.9%, 140/171). Gram-negative bacilli remain the predominant uropathogens in tertiary care settings, with an increasing burden of ESBL and carbapenem-resistance These findings underscore the need for continuous resistance surveillance, culture-guided therapy, and robust antimicrobial stewardship programs.</p></abstract>
		<kwd-group>
        <title>Keywords</title>
        <kwd>Urinary Tract Infection</kwd>
        <kwd>ESBL</kwd>
        <kwd>Carbapenem-resistance</kwd>
        <kwd>Uropathogens</kwd>
        <kwd>Escherichia coli</kwd>
        <kwd>Antimicrobial Susceptibility</kwd>
        <kwd>Multidrug-resistant Organisms</kwd>
		</kwd-group>
</article-meta>
</front>
</article>